Form 4: Caribou Biosciences Director Acquires Options in Recent Transaction

Director Scott Braunstein acquired options to purchase 40,500 shares of Caribou Biosciences common stock at $1.41 per share, vesting monthly until February 20, 2026.

Summary

• On February 20, 2025, Scott Braunstein, a director of Caribou Biosciences, Inc., acquired an option to purchase 40,500 shares of the company's common stock.
• The exercise price of the option is $1.41 per share.
• The options vest in monthly installments, with full vesting occurring on February 20, 2026, contingent upon continued service to the company.
• The option expires on February 19, 2035.
• Following the transaction, Braunstein directly owns options for 40,500 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an insider transaction. The acquisition of options could be interpreted as a positive sign of confidence, but it's not a strong indicator.

Positives

• The acquisition of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule implies an expectation of continued service by the reporting person.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Comparison to Industry Standards

• Option grants to directors are a common form of compensation in the biotechnology industry.
• The vesting schedule and exercise price would need to be compared to similar grants at comparable companies to assess their relative value and terms.

Stakeholder Impact

• The transaction has a minor impact on shareholders by increasing the potential dilution if the options are exercised.

Key Dates

Keywords

Caribou Biosciences, CRBU, Director, Scott Braunstein, Option, Stock, Acquisition, Vesting, Form 4